Vimarsana
Biggest News Aggregation in the World

Page 5 - Asthma Network News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Asthma Network. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Asthma Network Today - Breaking & Trending Today

Best Air Purifiers for Allergies, According to Testing and Experts - Vimarsana News

Best Air Purifiers for Allergies, According to Testing and Experts

The best air purifiers for allergies remove everything from pet hair to dust to pollen from the air. Here, find options from Dyson, Mila, Coway, and more.

Benralizumab Receives FDA Approval as Add-On Maintenance Therapy for Asthma - Vimarsana News

Benralizumab Receives FDA Approval as Add-On Maintenance Therapy for Asthma

The FDA approval of benralizumab for patients ages 6 to 11 with asthma follows the conclusions of the phase 3 TATE study.

FDA Approves Benralizumab to Treat Pediatric Patients Aged 6 to 11 Years With Severe Asthma - Vimarsana News

FDA Approves Benralizumab to Treat Pediatric Patients Aged 6 to 11 Years With Severe Asthma

Benralizumab was previously approved by the FDA in 2017 as an add-on maintenance therapy for patients 12 years and older.

FASENRA approved for treatment of children aged 6 to 11 with severe asthma - Vimarsana News

FASENRA approved for treatment of children aged 6 to 11 with severe asthma

Additional indication for pediatric patients with severe eosinophilic asthma ...

Benralizumab Receives FDA Approval as Add-On Maintenance Therapy for Children With Severe Asthma - Vimarsana News

Benralizumab Receives FDA Approval as Add-On Maintenance Therapy for Children With Severe Asthma

The approval of benralizumab (Fasenra) is supported by evidence from the phase 3 TATE study.

Source: ajmc.com